Clinical Trial Update: Effect of Salovum® on Pressure, Oxygen and Inflammation in Glioblastoma [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial is evaluating Salovum for effects on brain pressure, oxygenation, and inflammation in glioblastoma, currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glioblastoma

Drugs mentioned

• Salovum

Snippet

Sponsor: Peter Siesjö | Conditions: Glioblastoma | Phase 2 | Status: RECRUITING